Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
Clinical trial NCT01453088 · TERMINATED
Trial details
- NCT number
- NCT01453088
- Sponsor
- Hackensack Meridian Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-24
- Primary completion
- 2022-05-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.